Results 121 to 130 of about 608 (157)
Some of the next articles are maybe not open access.
Cross-Protective Immunity to Canine Adenovirus Type 2 by Canine Adenovirus Type 1 Vaccination
American Journal of Veterinary Research, 1978SUMMARY Vaccination of dogs (n = 6) with a single dose of canine adenovirus type 1 (cav-1) vaccine in 1 experiment prevented clinical disease that was otherwise produced in nonvaccinated (control) dogs (n = 6) after they were given aerosol, challenge exposure with canine adenovirus type 2 (cav-2).
J B, Emery, J A, House, W R, Brown
openaire +2 more sources
Differences in the E3 regions of the canine adenovirus type 1 and type 2
Virus Research, 1992Sequence analysis of a region extending between the pVIII and the fiber gene of Canine adenovirus type 1 (Cav-1, Utrecht) and type 2 (Cav-2, Manhattan) was performed. The results revealed a high level of identity between the two viruses when the pVIII gene and the N-terminal part of the fiber gene were compared.
T Linné
exaly +3 more sources
Genotypic characterization of type-2 variants of canine adenovirus
American Journal of Veterinary Research, 1986SUMMARY Two canine adenovirus (cav) isolates, apparently distinct from type-1 (Utrecht) and type-2 (Toronto A26/61) reference strains in their biochemical and/or immunologic properties, were submitted to DNA-restriction endonuclease analysis. Both isolates, designated IAF-81-2116 and IAF-75-95, appeared as genotypic variants of cav-2.
C, Hamelin, P, Jouvenne, R, Assaf
openaire +2 more sources
Sequence analysis of the canine adenovirus 2 fiber-encoding gene
Gene, 1995The gene coding for the fiber protein (Fip) of canine adenovirus type 2 (CAV-2) has been cloned and sequenced. The putative protein has 80% sequence similarity with the CAV-1 Fip. The observed differences may contribute to the known differences in cell tropism and virulence of the two types of CAV.
U B, Rasmussen +3 more
openaire +2 more sources
Localization of Inflammation and Virions in Canine Adenovirus Type 2 Bronchiolitis
American Review of Respiratory Disease, 1990Abstract Beagle puppies develop bronchiolar inflammation and histamine hyperresponsiveness with canine adenovirus type 2 (CAV2) infections. We determined the distribution of bronchiolar lesions and correlated inflammation with virions and bronchoalveolar lavage fluid (BALF) cytology. Nineteen beagle puppies were inoculated with tissue
R, Grad +7 more
openaire +2 more sources
Investigation of the presence of canine adenovirus (CAdV) in owned dogs in Northern Italy
Research in Veterinary Science, 2014 The use of a modified live canine adenovirus (CAdV) vaccine has greatly reduced the incidence of infectious canine hepatitis (ICH) in dogs. Nevertheless, cases of CAdV type 1 and 2 (CAdV-1 and CAdV-2) infection have been recently reported posing ...
Andrea Balboni +2 more
exaly +2 more sources
Nucleotide sequence of E1 region of canine adenovirus type 2
Virology, 1989The nucleotide sequence of the leftmost EcoRI-C fragment (0 to 11.3%) of canine adenovirus type 2 (CAd2) which could transform rodent cells morphologically but required additional sequences from 10 to 32 map units (m.u.) for full expression of its oncogenic potential was determined. The EcoRI-C fragment contains 3609 nucleotide base pairs (bp) encoding
R, Shibata +3 more
openaire +2 more sources
Journal of the American Veterinary Medical Association, 1980
SUMMARY A modified live strain of canine adenovirus type 2 (CAV-2) was developed and evaluated as a replacement for infectious canine hepatitis (canine adenovirus type 1; CAV-1) vaccines. In a genetic stability test, the vaccine strain remained nonpathogenic through five back passages in dogs and when given by the intranasal route.
E P, Bass, M A, Gill, W H, Beckenhauer
openaire +2 more sources
SUMMARY A modified live strain of canine adenovirus type 2 (CAV-2) was developed and evaluated as a replacement for infectious canine hepatitis (canine adenovirus type 1; CAV-1) vaccines. In a genetic stability test, the vaccine strain remained nonpathogenic through five back passages in dogs and when given by the intranasal route.
E P, Bass, M A, Gill, W H, Beckenhauer
openaire +2 more sources
Veterinary Journal, 2017 There is little information on sequence variation of canine adenovirus type 1 (CAdV-1), the aetiological agent of infectious canine hepatitis (ICH). This study reports hexon and fibre gene sequence variants of CAdV-1 in a dog with systemic ICH and a dog ...
Andrea Balboni +2 more
exaly +2 more sources
Canine Adenovirus Type 2-Induced Immunity to Two Canine Adenoviruses in Pups with Maternal Antibody
American Journal of Veterinary Research, 1975SUMMARY Twenty-four Beagle pups with high levels of maternal antibody to canine adenovirus type 1 (CAV-1) and canine adenovirus type 2 (CAV-2) were oronasally inoculated with CAV-2 at 4 weeks of age. The CAV-2 was isolated from pharyngeal swabs on postinoculation days 2 through 6. In spite of the infection, maternal antibody continued to decrease for 4
M, Appel, L E, Carmichael, D S, Robson
openaire +2 more sources